Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp.

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 470-476

  Fürnkranz, Ursula ^a   Nagl, Markus ^b   Gottardi, Waldemar ^b   Köhsler, Martina ^a   Aspöck, Horst ^a   Walochnik, Julia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; ANTIPROTOZOAL AGENT; CHLORINE DERIVATIVE; N CHLOROTAURINE; PHOSPHATE BUFFERED SALINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTACT LENS; CONTROLLED STUDY; CULTURE MEDIUM; CYST; DRUG CYTOTOXICITY; DRUG EFFICACY; EYE IRRITATION; GRANULOMATOSIS; GRANULOMATOUS AMOEBIC ENCEPHALITIS; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; TROPHOZOITE;

ACANTHAMOEBA; AMMONIUM CHLORIDE; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIPROTOZOAL AGENTS; BETA-ALANINE; HUMANS; HYDROGEN-ION CONCENTRATION; PARASITIC SENSITIVITY TESTS; TAURINE;

EID: 38649102504     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00715-07     Document Type: Article

References (45)

1. Arnitz, R., B. Sarg, H. W. Ott, A. Neher, H. Lindner, and M. Nagl. 2006. Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 6:865-869.
2. Cantin, A. M. 1994. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J. Clin. Investig. 93:606-614.
3. Cohen, E. J., C. J. Parlato, J. J. Arentsen, G. I. Genvert, R. C. Eagle, Jr., M. R. Wieland, and P. R. Laibson. 1987. Medical and surgical treatment of Acanthamoeba keratitis. Am. J. Ophthalmol. 103:615-625.
4. Demirci, G., G. M. Ay, L. V. Karabas, O. Altintas, G. S. Tamer, and Y. Caglar. 2006. Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage. Cornea 25:356-358.
5. Duarte, A. G., F. Sattar, B. Granwehr, J. F. Aronson, Z. Wang, and S. Lick. 2006. Disseminated acanthamoebiasis after lung transplantation. J. Heart Lung Transplant. 25:237-240.
6. Ficker, L., D. Seal, D. Warhurst, and P. Wright. 1990. Acanthamoeba keratitis - resistance to medical therapy. Eye 4(Pt 6):835-838.
7. Gottardi, W., R. Arnitz, and M. Nagl. 2007. N-Chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int. J. Pharm. 335:32-40.
8. Gottardi, W., and M. Nagl. 2002. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch. Pharm. (Weinheim) 335:411-421.
9. Gottardi, W., and M. Nagl. 2005. Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J. Antimicrob. Chemother. 55:475-482.
10. Hirukawa, Y., H. Nakato, S. Izumi, T. Tsuruhara, and S. Tomino. 1998. Structure and expression of a cyst specific protein of Acanthamoeba castellanii. Biochim. Biophys. Acta 1398:47-56.
11. Jones, D. B., G. S. Visvesvara, and N. M. Robinson. 1975. Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans. Ophthalmol. Soc. UK 95:221-232.
12. Kamel, A. G., H. Faridah, S. Yusof, A. Norazah, and M. A. Nakisah. 2004. A case of trauma related Acanthamoeba keratitis. Trop. Biomed. 21:135-138.
13. Khan, N. A. 2006. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol. Rev. 30:564-595.
14. Khunkitti, W., D. Lloyd, J. R. Furr, and A. D. Russell. 1996. The lethal effects of biguanides on cysts and trophozoites of Acanthamoeba castellanii. J. Appl. Bacteriol. 81:73-77.
15. Kilvington, S., R. Hughes, J. Byas, and J. Dart. 2002. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob. Agents Chemother. 46:2007-2009.
16. Kumar, R., and D. Lloyd. 2002. Recent advances in the treatment of Acanthamoeba keratitis. Clin. Infect. Dis. 35:434-441.
17. Lee, J. E., B. S. Oum, H. Y. Choi, H. S. Yu, and J. S. Lee. 2007. Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea 26:736-741.
18. Marciano-Cabral, F., and G. Cabral. 2003. Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16:273-307.
19. Marcinkiewicz, J., B. Nowak, A. Grabowska, M. Bobek, L. Petrovska, and B. Chain. 1999. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 98:371-378.
20. Nagl, M., and W. Gottardi. 1996. Enhancement of the bactericidal efficacy of N-chlorotaurine of inflammation samples and selected N-H compounds. Hyg. Med. 21:597-605.
21. Nagl, M., P. Hengster, E. Semenitz, and W. Gottardi. 1999. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J. Antimicrob. Chemother. 43:805-809.
22. Nagl, M., M. W. Hess, K. Pfaller, P. Hengster, and W. Gottardi. 2000. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob. Agents Chemother. 44:2507-2513.
23. Nagl, M., C. Larcher, and W. Gottardi. 1998. Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antivir. Res. 38:25-30.
24. Nagl, M., C. Lass-Florl, A. Neher, A. Gunkel, and W. Gottardi. 2001. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J. Antimicrob. Chemother. 47:871-874.
25. Nagl, M., B. Miller, F. Daxecker, H. Ulmer, and W. Gottardi. 1998. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - a phase I clinical study. J. Ocul. Pharmacol. Ther. 14:283-290.
26. Nagl, M., V. A. Nguyen, W. Gottardi, H. Ulmer, and R. Hopfl. 2003. Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br. J. Dermatol. 149:590-597.
27. Nagl, M., B. Pfausler, E. Schmutzhard, M. Fille, and W. Gottardi. 1998. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl. Bakteriol. Parasitenkd. Infektkrankh. Hyg. Abt. 1 Orig. 288:217-223.
28. Nagl, M., B. Teuchner, E. Pottinger, H. Ulmer, and W. Gottardi. 2000. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 214:111-114.
29. Neher, A., M. Nagl, E. Appenroth, M. Gstottner, M. Wischatta, F. Reisigl, M. Schindler, H. Ulmer, and K. Stephan. 2004. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114:850-854.
30. Page, F. C. 1976. An illustrated key to freshwater and soil amoebae. Scientific publication no. 34:11 ff. Freshwater Biological Association, Cumbria, England.
31. Radford, C. F., A. S. Bacon, J. K. Dart, and D. C. Minassian. 1995. Risk factors for Acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310:1567-1570.
32. Reinhard, T., and R. Sundmacher. 2000. Clinical aspects and therapy of Acanthamoeba keratitis. Ophthalmologe 97:446-459.
33. Romanowski, E. G., K. A. Yates, B. Teuchner, M. Nagl, E. U. Irschick, and Y. J. Gordon. 2006. N-Chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Investig. Ophthalmol. Vis. Sci. 47:2021-2026.
34. Seal, D. 2003. Treatment of Acanthamoeba keratitis. Expert Rev. Anti.-Infect. Ther. 1:205-208.
35. Seijo Martinez, M., G. Gonzalez-Mediero, P. Santiago, A. Rodriguez de Lope, J. Diz, C. Conde, and G. S. Visvesvara. 2000. Granulomatous amebic encephalitis in a patient with AIDS: isolation of Acanthamoeba sp. group II from brain tissue and successful treatment with sulfadiazine and fluconazole. J. Clin. Microbiol. 38:3892-3895.
36. Sharma, S., P. Garg, and G. N. Rao. 2000. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br. J. Ophthalmol. 84:1103-1108.
37. Sharma, S., G. Pasricha, D. Das, and R. K. Aggarwal. 2004. Acanthamoeba keratitis in non-contact lens wearers in India: DNA typing-based validation and a simple detection assay. Arch. Ophthalmol. 122:1430-1434.
38. Steinberg, J. P., R. L. Galindo, E. S. Kraus, and K. G. Ghanem. 2002. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clin. Infect. Dis. 35:e43-e49.
39. Teuchner, B., M. Nagl, A. Schidlbauer, H. Ishiko, E. Dragosits, H. Ulmer, K. Aoki, S. Ohno, N. Mizuki, W. Gottardi, and C. Larcher. 2005. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - a double-blind, randomized, phase-2 clinical trial. J. Ocul. Pharmacol. Ther. 21:157-165.
40. Visvesvara, G. S., and W. Balamuth. 1975. Comparative studies on related free-living and pathogenic amebae with special reference to Acanthamoeba. J. Protozool. 22:245-256.
41. Walochnik, J., M. Duchene, H. Eibl, and H. Aspock. 2003. Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches. Wien Klin. Wochenschr. 115(Suppl. 3):10-17.
42. Walochnik, J., E. Haller-Schober, H. Kolli, O. Picher, A. Obwaller, and H. Aspock. 2000. Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens-wearing keratitis patients in Austria. J. Clin. Microbiol. 38:3932-3936.
43. Walochnik, J., A. Hassl, K. Simon, G. Benyr, and H. Aspock. 1999. Isolation and identification by partial sequencing of the 18S ribosomal gene of free-living amoebae from necrotic tissue of Basilliscus plumifrons (Sauria: Iguanidae). Parasitol. Res. 85:601-603.
44. Walochnik, J., A. Obwaller, and H. Aspock. 2000. Correlations between morphological, molecular biological, and physiological characteristics in clinical and nonclinical isolates of Acanthamoeba spp. Appl. Environ. Microbiol. 66:4408-4413.
45. Yazdanbakhsh, M., C. M. Eckmann, and D. Roos. 1987. Killing of schistosomula by taurine chloramine and taurine bromamine. Am. J. Trop. Med. Hyg. 37:106-110.